Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis
2011 ◽
Vol 70
(7)
◽
pp. 1208-1215
◽
2001 ◽
2013 ◽
Vol 17
(12)
◽
pp. 1590-1595
◽
2011 ◽
Vol 24
(1)
◽
pp. 269-274
◽
2015 ◽
Vol 22
(Suppl 1)
◽
pp. A62.1-A62
2006 ◽
Vol 26
(12)
◽
pp. 1125-1131
◽
1998 ◽
Vol 57
(8)
◽
pp. 495-499
◽